Gagelmann N, Kroger N. Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend “when and for whom” in 2021? Haematologica. 2021;106:1794–804.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baker KS, et al. Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation. Blood. 2019;133:2790–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lawitschka A, Peters C. Long-term effects of myeloablative allogeneic hematopoietic stem cell transplantation in pediatric patients with acute lymphoblastic leukemia. Curr Oncol Rep. 2018;20:74.

Article  PubMed  Google Scholar 

Saglio F, et al. Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study. Bone Marrow Transpl. 2020;55:1918–27.

Article  CAS  Google Scholar 

Bunin N, et al. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study. Bone Marrow Transpl. 2003;32:543–8.

Article  CAS  Google Scholar 

Anderson BE, et al. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest. 2003;112:101–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, et al. Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity. Blood. 2004;103:3970–8.

Article  CAS  PubMed  Google Scholar 

Chen BJ, Cui X, Sempowski GD, Liu C, Chao NJ. Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood. 2004;103:1534–41.

Article  CAS  PubMed  Google Scholar 

Dutt S, et al. Naive and memory T cells induce different types of graft-versus-host disease. J Immunol. 2007;179:6547–54.

Article  CAS  PubMed  Google Scholar 

Zheng H, Matte-Martone C, Jain D, McNiff J, Shlomchik WD. Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia. J Immunol. 2009;182:5938–48.

Article  CAS  PubMed  Google Scholar 

Ruggeri L, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097–100.

Article  CAS  PubMed  Google Scholar 

Dunbar EM, et al. The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease. Haematologica. 2008;93:1852–8.

Article  PubMed  Google Scholar 

Ciurea SO, et al. Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation. Blood. 2017;130:1857–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang P, et al. NK cell predicts the severity of acute graft-versus-host disease in patients after allogeneic stem cell transplantation using antithymocyte globulin (ATG) in pretreatment scheme. BMC Immunol. 2019;20:46.

Article  PubMed  PubMed Central  Google Scholar 

Vela-Ojeda J, et al. Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation. Ann Hematol. 2006;85:113–20.

Article  CAS  PubMed  Google Scholar 

Clausen J, et al. Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation. Clin Exp Immunol. 2007;148:520–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim DH, et al. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation. Biol Blood Marrow Transpl. 2006;12:719–28.

Article  CAS  Google Scholar 

Mushtaq MU, et al. Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. Front Immunol. 2022;13:1005031.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCurdy SR, et al. Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning. Blood. 2022;139:608–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lang P, et al. Natural killer cell activity influences outcome after T cell depleted stem cell transplantation from matched unrelated and haploidentical donors. Best Pract Res Clin Haematol. 2011;24:403–11.

Article  CAS  PubMed  Google Scholar 

Leung W. Use of NK cell activity in cure by transplant. Br J Haematol. 2011;155:14–29.

Article  CAS  PubMed  Google Scholar 

Giebel S, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood. 2003;102:814–9.

Article  CAS  PubMed  Google Scholar 

Symons HJ, et al. Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation. Biol Blood Marrow Transpl. 2010;16:533–42.

Article  Google Scholar 

Leung W, et al. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood. 2011;118:223–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oevermann L, et al. KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. Blood. 2014;124:2744–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willemsen L, et al. Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab. Biol Blood Marrow Transpl. 2015;21:473–82.

Article  CAS  Google Scholar 

Shelikhova L, et al. Serotherapy-free regimen improves non-relapse mortality and immune recovery among the recipients of alphabeta Tcell-depleted haploidentical grafts: retrospective study in childhood leukemia. Transpl Cell Ther. 2021;27:330 e331-330 e339.

Article  Google Scholar 

Admiraal R, et al. Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis. Lancet Haematol. 2017;4:e183–91.

Article  PubMed  Google Scholar 

Lakkaraja M, et al. Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation. Blood Adv. 2022;6:1054–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leung W, et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol. 2004;172:644–50.

Article  CAS  PubMed  Google Scholar 

Leung W. Infusions of allogeneic natural killer cells as cancer therapy. Clin Cancer Res. 2014;20:3390–400.

Article